Amalgamated Bank’s ANI Pharmaceuticals ANIP Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $321K | Buy |
4,912
+106
| +2% | +$6.93K | ﹤0.01% | 1425 |
|
2025
Q1 | $322K | Buy |
4,806
+9
| +0.2% | +$603 | ﹤0.01% | 1406 |
|
2024
Q4 | $265K | Buy |
4,797
+74
| +2% | +$4.09K | ﹤0.01% | 1504 |
|
2024
Q3 | $282K | Buy |
4,723
+162
| +4% | +$9.67K | ﹤0.01% | 1494 |
|
2024
Q2 | $290K | Sell |
4,561
-203
| -4% | -$12.9K | ﹤0.01% | 1480 |
|
2024
Q1 | $329K | Sell |
4,764
-1,375
| -22% | -$95K | ﹤0.01% | 1454 |
|
2023
Q4 | $339K | Sell |
6,139
-583
| -9% | -$32.2K | ﹤0.01% | 1591 |
|
2023
Q3 | $390K | Buy |
6,722
+692
| +11% | +$40.1K | ﹤0.01% | 1529 |
|
2023
Q2 | $325K | Buy |
6,030
+867
| +17% | +$46.7K | ﹤0.01% | 1630 |
|
2023
Q1 | $205K | Sell |
5,163
-155
| -3% | -$6.15K | ﹤0.01% | 1793 |
|
2022
Q4 | $214K | Sell |
5,318
-201
| -4% | -$8.09K | ﹤0.01% | 1839 |
|
2022
Q3 | $177K | Sell |
5,519
-393
| -7% | -$12.6K | ﹤0.01% | 1896 |
|
2022
Q2 | $175K | Buy |
5,912
+415
| +8% | +$12.3K | ﹤0.01% | 1932 |
|
2022
Q1 | $155K | Buy |
5,497
+445
| +9% | +$12.5K | ﹤0.01% | 2035 |
|
2021
Q4 | $233K | Buy |
+5,052
| New | +$233K | ﹤0.01% | 1920 |
|